EPIAO

EPIAO

epoetin alfa

Manufacturer:

Shenyang Sunshine Pharmaceutical

Distributor:

B L H Trading
Concise Prescribing Info
Contents
Epoetin α
Indications/Uses
Anemia associated w/ chronic renal failure & in cancer patients treated w/ chemotherapy.
Dosage/Direction for Use
IV/SC Adult Initial dose: 100-150 IU/kg/wk for dialysis patient & 75-100 IU/kg/wk for nondialysis patient. Adjust dose for patients who respond w/ target Hb & hematocrit.
Contraindications
Uncontrolled HTN, hypersensitivity to mammalian cell-derived product & human albumin.
Special Precautions
Monitor hematocrit regularly to avoid excessive erythropoiesis.
Adverse Reactions
MIMS Class
Haematopoietic Agents / Supportive Care Therapy
ATC Classification
B03XA01 - erythropoietin ; Belongs to the class of other antianemic preparations. Used in the treatment of anemia.
Presentation/Packing
Form
EPIAO inj 10,000 IU
Packing/Price
1 mL x 1's
Form
EPIAO inj 4000 IU
Packing/Price
(pre-filled syringe) 1 mL x 1's; (vial) 1 mL x 10 × 1's; (vial) 1 mL x 1's
/thailand/image/info/epiao inj 4000 iu/4,000 iu x 1 ml?id=befe0bcc-bea2-4162-ae27-9fab00225d67
/thailand/image/info/epiao inj 4000 iu/4,000 iu x 1 ml?id=ff9d054d-c1a0-48b4-8483-9fab002159d3
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in